VRTXON

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation.

Nome da cripto VRTXON

Classificação No.3625

Capitalização de mercado $0.00

Capitalização de mercado totalmente diluída $0.00

Market share %

Vol. de negociação/Capitalização de mercado (24h) 18,479,963.26%

Fornecimento circulante 3.99845947

Fornecimento máximo 0

Fornecimento total 3.99845947

Taxa circulante %

Data de emissão --

O preço quando o ativo foi emitido pela primeira vez --

Máximo histórico 466.35223147502205, 2026-03-26

Menor preço 414.92035330237934, 2026-05-05

Blockchain pública VRTXON

Apresentação Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation.

Setor

Midias sociais

• Twitter

• Site oficial
• Explorador de blocos

Análise de entrada de fundos

etfindex:mc_etfindex_source Isenção de responsabilidade: Os dados fornecidos por cmc e não devem ser considerados como conselhos de investimento.